Inventor
SARKUNAM KANDHASAMY
IN16 patents
⚠️ This page may combine multiple inventors who share the name “SARKUNAM KANDHASAMY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
14 patentsUS12286428B2Apr 29, 2025
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO2 citations74
US10202390B2Feb 12, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO3 citations71
US9169252B2Oct 27, 2015
Heteroaryl substituted nicotinamide compounds
BRISTOL MYERS SQUIBB CO5 citations71
US11713312B2Aug 1, 2023
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO2 citations70
US11254663B2Feb 22, 2022
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO2 citations70
US12492186B2Dec 9, 2025
Bicyclic heterocyclic compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9527885B2Dec 27, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO1 citations50
US12319676B2Jun 3, 2025
Substituted amide compounds useful as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations48
US12030835B2Jul 9, 2024
Substituted amide compounds useful as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations47
US12227496B2Feb 18, 2025
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations46
US9643999B2May 9, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations40
US10618903B2Apr 14, 2020
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO0 citations39
US9580463B2Feb 28, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations39
US9499550B2Nov 22, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations39